optimal time for allo-hsct in aml
Published 3 years ago • 89 plays • Length 0:38Download video MP4
Download video MP3
Similar videos
-
0:53
go-flag: bridge therapy to allo-sct in r/r aml
-
1:25
how the role of transplant in all is evolving with the introduction of novel immunotherapies
-
4:31
labmt: impact of treatment prior to allogenic hct in mds
-
4:48
an insight into the management of cytopenias in mf
-
5:18
upfront treatment in transplant candidates
-
6:24
indiko biochemistry analyzer demonstration
-
9:11
chimeric antigen receptor car technique - creative biolabs (original version)
-
11:48
fab classification of aml pathology made easy | acute myeloid leukemia classification|#speedymedical
-
2:21
tab-cel for solid organ or allogeneic transplant recipients with ebv-ptld
-
8:34
hct in mds: cell source and conditioning type
-
1:47
shared treatment decision-making
-
3:40
master class in transplantation and hematology: highlights
-
1:29
restoring the hematolymphoid system in fanconi anemia
-
2:14
update on the aml treatment landscape
-
3:10
novel aml treament approaches
-
3:37
2020 uk aml trials update
-
4:39
aml & mds: mac or ric?
-
1:02
maintenance therapy following treatment for amyloidosis
-
3:08
hypomethylating agents in aml
-
1:49
bringing precision medicine and mrd into clinical strategies
-
0:59
idh inhibitors in aml
-
1:45
gvhd & gvl in secondary aml